Efficacy and Safety of Orelabrutinib for Previously Treated Marginal Zone Lymphoma.

J Hematol · 2025 · PMC12758041 · PMID 41488555

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Given the limited sample size and follow-up, the observed difference in CR rates did not reach statistical significance and should be interpreted with caution.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.